Otsuka Holdings Co., Ltd., commonly referred to as Otsuka, is a prominent Japanese pharmaceutical and nutraceutical company headquartered in Tokyo, Japan. Founded in 1921, Otsuka has established itself as a leader in the healthcare industry, focusing on innovative products that enhance the quality of life. The company operates extensively across Asia, Europe, and North America, with a diverse portfolio that includes prescription pharmaceuticals, consumer health products, and medical devices. Otsuka is renowned for its unique approach to drug development, particularly in the fields of psychiatry, oncology, and nephrology. Notable achievements include the introduction of groundbreaking treatments that address unmet medical needs. With a commitment to research and development, Otsuka continues to strengthen its market position, making significant contributions to global health and wellness.
How does Otsuka's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Otsuka's score of 66 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Otsuka Corporation reported total carbon emissions of approximately 111,977,000 kg CO2e, comprising 5,191,000 kg CO2e from Scope 1, 6,692,000 kg CO2e from Scope 2 (market-based), and a significant 102,000,000 kg CO2e from Scope 3 emissions. This represents a slight decrease from 2023, where total emissions were about 114,549,000 kg CO2e, with Scope 1 at 5,476,000 kg CO2e, Scope 2 (market-based) at 6,304,000 kg CO2e, and Scope 3 at 104,000,000 kg CO2e. Otsuka has set ambitious climate commitments, aiming for a 42% reduction in absolute Scope 1 and 2 emissions by 2030, using 2021 as the baseline year. Additionally, the company targets a 25% reduction in Scope 3 emissions from purchased goods and services and the use of sold products within the same timeframe. Furthermore, Otsuka has expressed a long-term goal of achieving net zero emissions across all scopes by 2050. These targets align with the Science Based Targets initiative (SBTi) and reflect Otsuka's commitment to addressing climate change and reducing its carbon footprint in line with global climate goals.
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 19,469,000 | 00,000,000 | 00,000,000 | - | - | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Otsuka has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Otsuka's sustainability data and climate commitments